九福来

PMAS Technology Improving Intracranial Immunity for Cerebral Stroke Won the Gold Award of Geneva Medical Invention

  • Categories:News
  • Time of issue:1524123600000

PMAS Technology Improving Intracranial Immunity for Cerebral Stroke Won the Gold Award of Geneva Medical Invention

  • Categories:News
  • Time of issue:2018-04-19 15:40

  The 46th International Exhibition of Inventions of Geneva, which lasted for five days, was successfully held in Switzerland on April 11. As a world-renowned event, the exhibition highlighted more than 1,000 inventions from 40 countries and regions, and thousands of exhibitors from around the world taking the spotlight and competing for a limited number of Gold Awards in this exhibition.

Awarding Site

  The technology invented by Jufeel Bio Group jointly with Zhejiang University, which is named the Application of Natural Plant Extracts on Improving Intracranial Auto-immunization and Protecting Injured Neurons of Cerebral Stroke Patients, won the Gold Award of Medical Health in this exhibition. The technology can improve the rehabilitation effects on brain atrophy and cerebral degeneration with no clinically observed side effects. The inventors of this technology are Professor Zhang Rongxuan, who is the chief biological scientist of Jufeel Biology and the School of Life Science of Changzhou University, and specially-appointed chief medical scientist, Professor Yan Weiqi.

Profess Zhang Rongxuan(left) Professor Yan Weiqi(right)

Awarding Site

  In this event, the function and effect of biotechnology essence PMAS and blood-brain barrier penetrating water-soluble PROG on degenerative diseases like cerebral stroke, discovered by Professor Zhang Rongxuan, from the School of Pharmacy and Life Science of Changzhou University and Professor Yan Weiqi, from Zhejiang University School of Medicine, have introduced the innovative spirit and ability of Chinese biotechnology to the world.

Gold Medal Winners Take Photos with the President of the Geneva Invention Exhibition

  Professor Yan points out that cerebral stroke is a kind of disease with extremely high mortality and disability rate in China and there have been no effective drugs so far; therefore it is very important to improve intracranial auto-immunization activity and protect injured neurons against hypoxia-ischemia. According to WHO materials, there is one patient suffering from cerebral stroke every six seconds in the world and most of them become disabled due to this disease. Therefore this technology has a tremendous scientific significance and social demand.

Back to list